Skip to content

336.522.8870Monday – Friday 7:45 AM – 4:15 PM

PulmonIx Research LLC

Transforming clinical care through cutting-edge research

Home
About Us
For Patients
For Sponsors
- Metrics
- Certifications
Employment
- Hiring Policy
Contact Us
- Contact
- Travel Info

Search:

Home
About Us
For Patients
For Sponsors
- Metrics
- Certifications
Employment
- Hiring Policy
Contact Us
- Contact
- Travel Info

New COPD Triple Inhaler

New COPD triple inhaler, Trelegy, approved for COPD exacerbations – PI: Murali Ramaswamy.

Read Full Article

Category: NewsBy Pulmonix May 3, 2018

Post navigation

NextNext post:Dupulimab – New Class Agent Injectable in Asthma

Related Posts

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
May 21, 2026

Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study
May 21, 2026

PULMONIX VOLUNTEERS WITH THE KELLIN FOUNDATION TO SUPPORT FAMILIES IN NEED
July 18, 2025

PULMONIX NAMED FINALIST FOR TRIAD BUSINESS JOURNAL’S BEST PLACES TO WORK
May 29, 2025

© PulmonIx Research, LLC 2026 | Site by LaG